
Sign up to save your podcasts
Or


In this episode, Jamie and Melissa Anne unpack reports of a CDC-funded study in Guinea-Bissau that would randomize newborns to receive the Hepatitis B vaccine at birth versus a delayed dose, which is framed by RFK Jr. as “gold standard science.” They break down what decades of evidence say about Hep B transmission and why the birth dose matters, then dig into the ethical red flags of testing delayed protection in a hyper-endemic setting, including concerns about vulnerable populations, justice, and preventable harm. We also connect the this "gold standard science" experiment to research ethics frameworks and discuss potential investigator bias and “cronyism” concerns. We also ask why this story hasn’t gotten more mainstream attention?
For more head to Nursingthenation.substack.com.
By Jamie Bourgeois & Melissa Anne DuboisIn this episode, Jamie and Melissa Anne unpack reports of a CDC-funded study in Guinea-Bissau that would randomize newborns to receive the Hepatitis B vaccine at birth versus a delayed dose, which is framed by RFK Jr. as “gold standard science.” They break down what decades of evidence say about Hep B transmission and why the birth dose matters, then dig into the ethical red flags of testing delayed protection in a hyper-endemic setting, including concerns about vulnerable populations, justice, and preventable harm. We also connect the this "gold standard science" experiment to research ethics frameworks and discuss potential investigator bias and “cronyism” concerns. We also ask why this story hasn’t gotten more mainstream attention?
For more head to Nursingthenation.substack.com.